Shingles is “one of the worst pains in medicine.” A vaccine is highly effective at preventing it, but many people don’t get ...

GSK has turned to Brooke Shields to get the message out about shingles vaccination. | GSK has turned to Brooke Shields to get ...

Melbourne, Australia The Government has expanded access to GSK's shingles vaccine, Shingrix, to cover individuals aged 18 ...

A vaccine for the prevention of shingles in adults aged 50 and over and those aged 18 and over at increased risk KUALA LUMPUR ...

GSK plc (LSE/NYSE: GSK) is partnering with Brooke Shields, as part of its THRIVE@50+ campaign, to encourage people 50 and ...

Australians ages 18 to 64 who are classed as "moderate to high risk" will be able to get the shingles jab. ...

4 PHN is the most common complication of shingles, occurring in 5–30% of all shingles cases, from findings in various studies.5 GSK cautions investors that any forward-looking statements or ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...